5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, GP; Li, DC; Li, FY; Liu, Z; Wang, H; Wang, ZP; Zhao, Y | 1 |
| Berns, A; Bex, A; Horenblas, S; Vooijs, M | 1 |
2 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Bladder Cancer
| Article | Year |
|---|---|
[Double-mutated oncolytic adenovirus combined with gemcitabine for treating an orthotopic nude mouse model of bladder cancer].
Topics: Adenoviridae; Administration, Intravesical; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Galactosides; Gemcitabine; Indoles; Mice; Mice, Nude; Models, Animal; Urinary Bladder Neoplasms | 2013 |
Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination.
Topics: Animals; beta-Galactosidase; Disease Models, Animal; Dose-Response Relationship, Drug; Estrogen Antagonists; Galactosides; Gene Targeting; Genes, Reporter; Genes, Tumor Suppressor; Indoles; Integrases; Mice; Mice, Transgenic; Mutagenesis, Insertional; Mutation; Proteins; Receptors, Estrogen; Recombination, Genetic; RNA, Untranslated; Tamoxifen; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium; Viral Proteins | 2002 |